Dipyridamole electrocardiography test for the assessment of the severity of coronary artery disease.
スポンサーリンク
概要
- 論文の詳細を見る
The purpose of this study was to investigate the relationship of dipyridamole-induced ST changes to the severity of coronary artery disease. The subjects were 100 patients without myocardial infarction who underwent coronary arteriography for the diagnosis of coronary artery disease. The dipyridarnole injection test (D) (0.568 mg/kg/4 min), and symptom-limited treadmill exercise test (T) were performed separately. Body surface electrocardiographic mapping of 87 leads was performed in both tests. The incidences of significant ST depression ≤ 0.10 mV, number of leads showing significant ST depression (nST) and the maximal voltage of ST depression (maxST) in D and T were compared to the number of diseased coronary arteries. In patients without significant coronary stenosis (0VD group), the incidence of ST depression in the dipyridamole test was significantly lower than that in the treadmill test (D 9% vs T 47%, p<0.01). While, in one vessel disease (1VD), two vessel disease (2VD), and three vessel disease (3VD)groups, there was no significant difference in the incidence of ST depression between the dipyridamole test and the treadmill test (in 1VD, D 44% vs. T 65%; in 2VD, D 67% vs. T 93%; and in 3VD D 93% vs. T, 96%). In the dipyridamole test, nST was 0.6±2.4 in 0VD, 4.5±6.9 in 1VD, 4.1±4.5 in 2VD, and 10.6±8.1 in 3VD. Significant differences were found between 0VD and 1VD (P<0.05), 0VD and 3VD (P<0.01). 1VD and 3VD (P<0.01), and 2VD and 3VD (p<0.01). The maxST in the dipyridamole test was 0.02±0.04 mV in 0VD, 0.10±0.12 mV in 1VD. 0.13±0.11 mV in 2VD, and 0.22±0.11 mV in 3VD. Significant differences were found between 0VD and 1VD (p<0.01), 0VD and 2VD (p<0.01), 0VD and 3VD (p<0.01), 1VD and 3VD (p<0.01), and 2VD and 3VD (P<0.01). For the diagnosis of 3VD, the dipyridamole ECG test had as high a sensitivity (93% vs 96%), higher specificity (68% vs 38%, p<0.01), and higher predictive accuracy (75% vs 54%, p<0.01) than the treadmill test. For the detection of one or more stenotic coronary arteries, the dipyridamole test had a lower sensitivity (70% vs 85%, p<0.05), but higher specificity (91% vs 53%, p< 0.01), and as high a predictive accuracy (77% vs 74%) compared with the treadmill test. This study demonstrated that the dipyridamole ECG test was useful in stratifying the severity of coronary artery disease. Dipyridamole ECG was both sensitive and specific for the detection of 3VD.
- 社団法人 日本循環器学会の論文
社団法人 日本循環器学会 | 論文
- ANTIARRHYTHMIC AND MYOCARDIAL METABOLIC EFFEDTS OF VERAPAMIL DURING CORONARY ARTERY REPERFUSION
- EFFECTS OF PROPRANOLOL AND DILTIAZEM ON THE RATE OF HIGH-ENERGY PHOSPHATE METABOLISM IN REPERFUSED RAT HEARTS
- SIMULTANEOUS DUAL MYOCARDIAL IMAGING WITH IODINE-123-β-METHYL IODOPHENYL-PENTADECANOIC ACID (BMIPP) AND THALLIUM-201 IN PATIENTS WITH CORONARY HEART DISEASE
- EFFECTS OF L-CARNITINE ON VENTRICULAR ARRHYTHMIAS IN DOGS WITH ACUTE MYOCARDIAL ISCHEMIA AND A SUPPLEMENT OF EXCESS FREE FATTY ACIDS
- EFFECTS OF L-CARNITINE ON TISSUE LEVELS OF ACYL CARNITINE, ACYL COENZYME A AND HIGH ENERGY PHOSPHATE IN ISCHEMIC DOG HEARTS